Nakamura H, Usa T, Motomura M, Ichikawa T, Nakao K, Kawasaki E, Tanaka M, Ishikawa K, Eguchi K
The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki City, Nagasaki, Japan.
J Endocrinol Invest. 2008 Oct;31(10):861-5. doi: 10.1007/BF03346432.
We determined the autoantibody profile in autoimmune thyroid diseases (AITD) and examined the distribution of thyroid-related autoantibodies in other autoimmune disorders.
We tested sera from 234 patients with Graves' disease (GD), 130 with Hashimoto's thyroiditis (HT), 249 with other autoimmune diseases, and 50 healthy controls by enzyme-linked immunosorbent assay or radioimmunoassay.
Autoantibodies except TSH receptor antibody (Ab), anti-thyroglobulin (Tg) Ab and anti-thyroid peroxidase (TPO) Ab were not significantly prevalent in patients with AITD despite a significantly high elevation of thyroid-related Ab. Significant prevalence of autoantibodies related to AITD was observed in type 1 diabetes patients. Elevation of anti-Tg Ab was seen in patients with primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH), and anti-TPO Ab was elevated in patients with PBC. Although the prevalence of anti-acetylcholine receptor Ab and systemic lupus erythematosus (SLE)- related Ab was significant in AIH, primary Sjögren's syndrome (pSS)-related Ab were also found in both liver diseases. In myasthenia gravis (MG) patients, thyroid-related Ab and pSS-related Ab were detected in both MG groups, although SLE-related Ab were limited to the anti-muscle specific kinase Ab-positive MG patients. In patients with connective tissue diseases, anti- Tg Ab and anti-TPO Ab were significantly prevalent.
Thyroid-related Ab were significantly elevated in all autoimmune diseases. Conversely, the elevations of Ab were not significant in the patients with AITD, suggesting a close relationship between AITD and other immune-mediated diseases.
我们确定了自身免疫性甲状腺疾病(AITD)中的自身抗体谱,并研究了甲状腺相关自身抗体在其他自身免疫性疾病中的分布情况。
我们通过酶联免疫吸附测定或放射免疫测定法检测了234例格雷夫斯病(GD)患者、130例桥本甲状腺炎(HT)患者、249例其他自身免疫性疾病患者以及50例健康对照者的血清。
尽管甲状腺相关抗体显著升高,但除促甲状腺激素受体抗体(Ab)、抗甲状腺球蛋白(Tg)Ab和抗甲状腺过氧化物酶(TPO)Ab外,其他自身抗体在AITD患者中并不显著普遍存在。1型糖尿病患者中观察到与AITD相关的自身抗体显著普遍存在。原发性胆汁性肝硬化(PBC)和自身免疫性肝炎(AIH)患者中可见抗Tg Ab升高,PBC患者中抗TPO Ab升高。虽然抗乙酰胆碱受体Ab和系统性红斑狼疮(SLE)相关Ab在AIH中显著普遍存在,但在这两种肝脏疾病中也发现了原发性干燥综合征(pSS)相关Ab。在重症肌无力(MG)患者中,两个MG组均检测到甲状腺相关Ab和pSS相关Ab,尽管SLE相关Ab仅限于抗肌肉特异性激酶Ab阳性的MG患者。在结缔组织病患者中,抗Tg Ab和抗TPO Ab显著普遍存在。
所有自身免疫性疾病中甲状腺相关Ab均显著升高。相反,AITD患者中抗体升高并不显著,这表明AITD与其他免疫介导疾病之间存在密切关系。